Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1007 results for "us fda"

Controversy Continues Over Muscular Dystrophy Drug, Despite FDA Approval
NPR

Controversy Continues Over Muscular Dystrophy Drug, Despite FD...

When 15-year-old Billy Ellsworth stepped up to the microphone at a Food and Drug Administration public meeting in April, he had no way to know he was part of a historic shift in how the government considers the desires of patients and their ... NPR, 1 day ago
FDA approves first ever drug for muscular dystrophy HealthMediciNet.com, 1 hour ago
FDA OKs first Duchenne muscular dystrophy drug Equilibrio Informativo, 7 hours ago
[x]  
NewsMax.com

FDA Is Striking Dangerous Deals With Reporters

Is the Food and Drug Administration manipulating what stories we get on its decisions? That's the suggestion of a new article in Scientific American on the ways that the FDA controls who sees information when, and how journalists can report on ...
 NewsMax.com19 hours ago FDA's Dangerous Deals With Reporters  Bloomberg View1 day ago
Scientific American

Spinning science news: How the FDA keeps manipulating the media

This article was originally published by Scientific American . It was a faustian bargain — and it certainly made editors at National Public Radio squirm. The deal was this: NPR, along with a select group of media outlets, would get a ...
 Salon13 hours ago How the FDA Manipulates the Media  Scientific American4 days ago

Integrator Alert: Demand Time (and Changes) in the FDA's Move Limiting Access and Increasing Costs of Dietary Supplements

Removal of many dietary supplements from the market. Increased prices for patients and consumers. Limited access to key nutritional tools for practitioners who have used them safely for decades. Charges like these against a proposal of the US Food ...
 Huffington Post13 hours ago
Business Insider

A top journalist is suing the FDA over its use of a banned and secretive practice to manipulate the news

The US Food and Drug Administration (FDA) may reportedly still engage in a banned practice that manipulates popular news coverage, and a few of America's top science journalists are railing against the government organization because of it. One ...
 Business Insider15 hours ago
[x]  

Aurobindo Pharma, Cadila recall drugs from US market

According to US FDA, the recall is due to failed dissolution specifications; specification result for dissolution was identified during three-month stability testing Aurobindo Pharma and Cadila Healthcare have recalled over 25,500 bottles of two ...
 Express Computer India23 hours ago

Allergan wins FDA approval to market new NATRELLE INSPIRA Cohesive breast implants

Allergan plc (NYSE: AGN) today announced the company has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA ® Cohesive breast implants, offering women undergoing reconstruction, augmentation or revision ...
 News-Medical.Net9 hours ago Allergan Announces FDA Approval of NATRELLE INSPIRA ® Cohesive Breast Implants  Stockwatch1 day ago 9/23/16 - Allergan Announces FDA Approval of NATRELLE INSPIRA® Cohesive Breast Implants  Pharmacy Choice1 day ago FDA approves Lannett's Buprenorphine and Naloxone sublingual tablets  Seeking Alpha5 days ago
[x]  

Inside The FDA: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) and its Bladder Cancer Treatment, Apaziquone

, the FDA's Oncologic Drugs Advisory Committee met to evaluate and discuss a drug called apaziquone. Apaziquone is a development stage bladder cancer treatment, which small cap biotech Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is investigating as ...
 4 Traders22 hours ago Spectrum bladder cancer drug not effective: U.S. FDA panel  Reuters1 week ago
HCPLive

FDA OKs Biosimilar to Adalimumab for Inflammatory Diseases

The US Food and Drug Administration (FDA) has approved adalimumab-atto ( Amjevita , Amgen, Inc), a biosimilar to adalimumab ( Humira , AbbVie, Inc; approved in December 2002), for the treatment of multiple inflammatory diseases. The biosimilar is ...
 Diabetes Care1 day ago FDA Approves Amgen's AMJEVITA (Adalimumab-Atto) For Treatment Of Seven Inflammatory Diseases  PR Newswire1 day ago U.S. FDA approves Amgen's cheaper copy of arthritis drug Humira  Reuters UK1 day ago FDA Approves Adalimumab-atto, a Biosimilar of Humira  The-Rheumatologist.org1 day ago
[x]  
Med India

Aurobindo gets tentative FDA approval for HIV drug

HYDERABAD, India — Aurobindo Pharma Ltd. has gained tentative approval from the Food and Drug Administration for dolutegravir 50 mg, an HIV medication. Aurobindo said Thursday that the move enables the company to launch the product, a generic ...
 Chain Drug Review1 day ago ViiV Healthcare welcomes the FDA's Tentative Approval of the first generic dolutegravir from Aurobindo Pharma  Pharmacy Choice1 day ago US FDA gives tentative approval for Aurobindo's generic HIV drug  Business Standard3 days ago AUROBINDO PHARMA : US FDA gives tentative approval for Aurobindo`s generic HIV drug  4 Traders1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less